WASHINGTON, D.C. – Today, U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Committee on Health, Education, Labor, and Pensions, celebrated the announcement that AstraZeneca will cap the cost of more of their new inhalers at $35. This announcement comes after Baldwin launched an investigation into the extremely high prices pharmaceutical companies charge for inhalers that 25...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
